Chua Wee - Academia.edu (original) (raw)

Chua Wee

Related Authors

rastu karyana

Guillermo Jiménez

Sameh Morcos

Andrew Benko

Université de Sherbrooke (University of Sherbrooke)

Adrian Covic

Adrian Covic

University of Medicine and Pharmacy "Gr. T. Popa", Iasi

Uploads

Papers by Chua Wee

Research paper thumbnail of n-Acetylcysteine for prevention of iodinated contrast- induced nephropathy in computed tomography angiography procedures in patients with chronic kidney disease

N-Acetylcysteine (NAC) is used in the prevention of contrast-induced nephropathy (CIN) in our ins... more N-Acetylcysteine (NAC) is used in the prevention of contrast-induced nephropathy (CIN) in our institution. The variation in clinical effects as a result of dosage differences between intravenous (IV) and oral administration warrants further investigation. This study primarily aimed to evaluate the incidence of CIN in patients with renal impairment, comparing those who received IV NAC with those receiving oral NAC. This was an observational, retrospective study conducted from 1st January, 2007 to 31st March, 2010. The study included 94 renally impaired patients (baseline glomerular filtration rate (eGFR) < 70 ml/min/1.73 m 2) who had undergone iodinated-contrast procedure, and received either IV NAC (150 mg/kg pre-procedure, then 50 mg/kg post-procedure) or oral NAC (600 mg twice daily for one day before the procedure, then for two days after the procedure). The changes in serum creatinine (SCr) over time: pre-procedure, post-procedure 24, 48 and 72 h for both regimens were record...

Research paper thumbnail of n-Acetylcysteine for prevention of iodinated contrast- induced nephropathy in computed tomography angiography procedures in patients with chronic kidney disease

N-Acetylcysteine (NAC) is used in the prevention of contrast-induced nephropathy (CIN) in our ins... more N-Acetylcysteine (NAC) is used in the prevention of contrast-induced nephropathy (CIN) in our institution. The variation in clinical effects as a result of dosage differences between intravenous (IV) and oral administration warrants further investigation. This study primarily aimed to evaluate the incidence of CIN in patients with renal impairment, comparing those who received IV NAC with those receiving oral NAC. This was an observational, retrospective study conducted from 1st January, 2007 to 31st March, 2010. The study included 94 renally impaired patients (baseline glomerular filtration rate (eGFR) < 70 ml/min/1.73 m 2) who had undergone iodinated-contrast procedure, and received either IV NAC (150 mg/kg pre-procedure, then 50 mg/kg post-procedure) or oral NAC (600 mg twice daily for one day before the procedure, then for two days after the procedure). The changes in serum creatinine (SCr) over time: pre-procedure, post-procedure 24, 48 and 72 h for both regimens were record...

Log In